Stock listing

ASX:NTI Neurotech International Ltd. Share Price

Follow Neurotech International Ltd. into a list and get an email when it puts out news.

Share price · ASX:NTI

$0.017 AUD 0.000 (0.0%)

Close on Oct 19, 2026

Since Jul 6, 2026 0.0% · daily closes, Jul 6, 2026 – Oct 19, 2026, adjusted for splits
Day range
$0.016 – $0.017 AUDOct 19, 2026
Volume
1.75M sharesOct 19, 2026
Market value
$22.49M AUDAt the close on Oct 19, 2026 · price × 1.32B shares outstanding
Neurotech International Ltd. logo
Ticker
ASX:NTI
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
ASX
Currency
AUD

What changed lately

Latest news

NTI Doses First Patient in Phase 3 Beyond Harmony ASD Study

Sep 20, 2026

Receipt of Binding Commitments for $4.5m Placement

Aug 3, 2026

Neurotech secures $3.15 million R&D tax incentive loan

Jul 14, 2026

US FDA clears IND for NTI164

Jul 13, 2026

NTI secures Notices of Allowance for US patent applications

Jul 1, 2026

NTI initiates First Clinical Site for Phase 3 ASD Trial

Mar 16, 2026

Appendix 4D & Half Year Report

Feb 26, 2026

Positive 90-day GLP toxicology study results in non-rodents

Feb 22, 2026

Approval received for NTI164 Phase 3 Clinical Study in ASD

Feb 1, 2026

Quarterly Activities/Appendix 4C Cash Flow Report

Jan 29, 2026

All Neurotech International Ltd. news

Decks

Neurotech International Ltd. on 6ix

Sector
Health care
Industry
Biotechnology
News releases
13 in the last 12 months · 141 in all · newest Sep 20, 2026 · oldest 2016
Decks
34 decks · latest Oct 20, 2026

Log in to ask 6ix AI your own questions about Neurotech International Ltd.